MCPIP-1, Alias Regnase-1, Controls Epithelial Inflammation by Posttranscriptional Regulation of IL-8 Production by Dobosz, Ewelina et al.
E-Mail karger@karger.com
 Research Article 
 J Innate Immun 2016;8:564–578 
 DOI: 10.1159/000448038 
 MCPIP-1, Alias Regnase-1, Controls Epithelial 
Inflammation by Posttranscriptional Regulation 
of IL-8 Production 
 Ewelina Dobosz a    Mateusz Wilamowski b    Maciej Lech c    Beata Bugara b    
Jolanta Jura b    Jan Potempa a, d    Joanna Koziel a  
 Departments of  a  Microbiology and  b  General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, 
Jagiellonian University,  Krakow , Poland;  c  Medizinische Klinik und Poliklinik IV, University Hospital of Ludwig 
Maximilian University,  Munich , Germany;  d  Center for Oral Health and Systemic Disease, University of Louisville 
School of Dentistry, University of Louisville,  Louisville, Ky. , USA
 
MCPIP-1 controls the IL-8 mRNA level. In conclusion, we
uncovered a novel IL-8-dependent mechanism via which 
MCPIP-1 maintains epithelial homeostasis. This study reveals 
for the first time that MCPIP-1 plays a crucial anti-inflamma-
tory role not only in myeloid cells but also in epithelial cells. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 A layer of epithelial cells is an essential component of 
the physiological barrier and the first line of defense 
against microbial pathogens. An important innate im-
mune function of the epithelium is to recruit immune 
cells and maintain homeostasis. Moreover, epithelial cells 
constantly exposed to microbial ligands recognize patho-
gen-associated molecular patterns (PAMPs) and may ini-
tiate innate immune inflammatory responses needed for 
pathogen clearance during infection  [1–3] . The crucial 
cytokine produced by epithelium in response to bacterial 
invasion is CXCL8/interleukin (IL)-8, which determines 
the recruitment of neutrophils to the site of infection  [4, 
5] . The uncontrolled secretion of this proinflammatory 
cytokine can lead to excessive activation and chemotaxis 
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 Abstract 
 Pattern recognition receptors are critical for the detection of 
invading microorganisms. They activate multiple pathways 
that lead to the induction of proinflammatory responses and 
pathogen clearance. The intensity and duration of this im-
mune reaction must be tightly controlled spatially and tem-
porally in every tissue by different negative regulators. We 
hypothesized that monocyte chemoattractant protein-1-in-
duced protein-1 (MCPIP-1) might play a role in maintaining 
immune homeostasis in the epithelium both under physio-
logical conditions and upon bacterial infection. To this end, 
we examined the distribution of the MCPIP-1 transcript and 
protein in various tissues. The MCPIP-1 protein level was 
higher in epithelial cells than in myeloid cells. MCPIP-1 ex-
erted RNase activity towards the interleukin (IL)-8 transcript 
and the lifespan of IL-8 was determined by the presence of 
the stem-loops/hairpin structures at the 3 ′ UTR region of IL-8 
mRNA. Moreover, using fully active, purified recombinant 
MCPIP-1 protein, we elucidated the mechanism by which 
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of neutrophils  [6] . Therefore, inflammation in the host 
epithelium must be regulated to prevent tissue damage 
and maintain epithelial homeostasis after microbial in-
fection. Thus, the crucial task of the epithelial tissue is to 
control responses to PAMPs, not only by limiting TLR 
receptor expression, but also by expressing cytoplasmic 
negative regulators of cell signaling. These regulators can 
be constitutively expressed or upregulated during inflam-
mation, thereby preventing excessive destruction of in-
flamed tissue  [7–10] . 
 Monocyte chemoattractant protein-1-induced pro-
tein-1 (MCPIP-1), also known as Regnase-1, was recently 
described as a multifunctional regulator of innate immu-
nity  [11] . Originally, MCPIP-1 was identified as a protein 
encoded by the  ZC3H12A gene, a member of the CCCH-
type zinc finger gene family  [12] . Increased  ZC3H12A ex-
pression has been observed in myeloid cells upon stimu-
lation with various molecules, such as MCP-1, IL-1β, 
PMA, and TLRs agonists, and in response to bacterial in-
fections  [13, 14] . Moreover, recently published data indi-
cate that MCPIP-1 plays an important role in the suppres-
sion of miRNA activity and biogenesis  [15] , angiogenesis 
 [16] , adipogenesis  [17] , and osteoclastogenesis  [18] . Fur-
thermore, the protein was initially characterized as a tran-
scription factor for apoptotic gene families, since its 
structure possesses a putative nuclear localization signal 
sequence and two potential proline-rich activation do-
mains  [12] . Other studies have focused on the role of 
MCPIP-1 in inflammation exerted via its ubiquitin-asso-
ciated domain, which provides the deubiquitinase activ-
ity that results in the negative regulation of the NF-κB 
signaling pathway  [19, 20] . The PilT N-terminus domain 
of MCPIP-1 possesses RNase activity that targets the 
mRNA of proinflammatory cytokines such as  IL-6 , IL-1β , 
and  IL-12p40  [13, 21, 22] . Moreover, in vivo studies have 
revealed that MCPIP-1-deficient mice develop hyperre-
sponsiveness upon exposure to some PAMPs  [20, 21] . 
However, despite the general consensus that MCPIP-1 is 
a potent negative regulator of inflammation, the mecha-
nism via which it exerts this function remains poorly un-
derstood. 
 Although, MCPIP-1 has already been described as a 
potent inhibitor of proinflammatory cytokine secretion 
in myeloid cells  [23, 24] , its role in the pathophysiol-
ogy and homeostasis of the epithelium remains unex-
plored. This study investigated the regulatory function
of MCPIP-1 and the underlying mechanism by which it 
affects the IL-8 level in epithelial cells under physiological 
conditions as well as upon infection. 
 Materials and Methods 
 Reagents 
 Fetal bovine serum (FBS), high-glucose DMEM, RPMI-1640, 
Dulbecco’s PBS without Ca 2+ /Mg 2+ , penicillin/streptomycin, and 
Opti-MEM medium were from Gibco. SYBR Green JumpStart Taq 
ReadyMix, PMSF (phenylmethanesulfonyl fluoride), and puromy-
cin were obtained from Sigma. 
 Cell Cultures 
 HeLa human cervix epithelial carcinoma, Caco-2 human colon 
epithelial cancer, HEK293T human embryonic kidney, Hep-G2 
human hepatocellular liver carcinoma, KATO III human stomach 
carcinoma, and KB human cervix epithelial carcinoma cell lines 
were obtained from the American Type Culture Collection 
(ATCC). Human skin keratinocytes, kindly provided by Dr. 
Krystyna Staliska (Faculty of Biochemistry, Biophysics and Bio-
technology, Jagiellonian University) were maintained in high-glu-
cose DMEM supplemented with 10% FBS and 1% penicillin/strep-
tomycin. THP-1 human monocytic cells and U937 human leu-
kemic monocyte lymphoma cells, obtained from ATCC, were 
cultured in RPMI-1640 medium supplemented with 10% FBS. 
TIGKs (telomerase-immortalized gingival keratinocytes), kindly 
provided by Prof. Richard Lamond (University of Louisville School 
of Dentistry), were routinely cultured in KBM-Gold TM keratino-
cyte basal medium supplemented with Single Quotes TM (Lonza). 
For experiments, cells were cultured under standard conditions 
(37   °   C and 5% CO 2 ) and seeded on 12-well plates (TPP). Human 
monocyte-derived macrophages (hMDMs) differentiated from 
peripheral blood mononuclear cells (PBMCs) as described previ-
ously were seeded on 24-well plates (Sarstedt) and cultured under 
standard conditions in RPMI-1640 medium supplemented with 
10% FBS. The purity of monocyte-derived macrophages was veri-
fied by the analysis of macrophage surface markers by flow cytom-
etry. Briefly, the hMDM phenotype was evaluated by immuno-
fluorescence staining for CD14 (DakoCytomation), CD16 (Dako-
Cytomation), CD11b (Becton Dickinson), and CD209 (Becton 
Dickinson). The routine procedure used in our laboratory yields 
at least 90% cells positive for the first three antigens, with fewer 
than 1% of cells staining with anti-CD209 antibodies  [25] . Prima-
ry monocytes (Mo) were isolated from the PBMC fraction using 
the Human Monocyte Enrichment Set-DM (BD IMag). Further 
supplementation of Mo culture media (RPMI with 10% FBS and 
1% penicillin/streptomycin) with IL-4 (500 U/ml) and GM-CSF 
(10 ng/ml) (R&D Systems) led to differentiation of the primary 
monocytes into monocyte-derived dendritic cells (moDCs). Neu-
trophils were isolated from granulocyte-enriched fractions by 
mixing with a 1% solution of polyvinyl alcohol in PBS. After
30 min at room temperature, neutrophils were separated from red 
blood cells by harvesting the upper phase; the remaining erythro-
cytes were subsequently removed by hypotonic lysis. Blood was 
obtained from the Red Cross, Krakow, Poland, which deidentifies 
blood materials as appropriate for human subject confidentiality 
assurances. Thus, this manuscript adheres to appropriate exclu-
sions from human subject approval. 
 Bacteria Preparation, Cell Infection, and Cell Stimulation 
 Escherichia coli  strain (ATCC 25922) was inoculated from pre-
culture stocks into 10 ml of LB Broth (Bio Shop) media and grown 
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(180 rpm). Prior to infection, bacteria were collected by centrifuga-
tion (5,000 rpm for 5 min), washed with PBS, and resuspended in PBS 
at the desired OD 600 . Infection of HeLa and Caco-2 cells with  E. coli 
 was carried out at an MOI (multiplicity of infection) of 1: 5, in DMEM 
without antibiotics at 37  °  C. Three hours postinfection, the cells were 
rinsed four times with ice-cold PBS. After the final wash, medium 
supplemented with antibiotics (1% penicillin/streptomycin) was 
added, and the cells were further cultured for the desired time.
 For colony-forming unit (CFU) determination, after the wash-
ing step, cells were cultured in media containing antibiotics for an 
additional hour, followed by the plating of cell lysates onto LB agar 
for the counting of intracellular bacteria.
 Calcium Mobilization 
 Neutrophils resuspended in HBSS (Hanks Balanced Salt Solu-
tion; Lonza) were loaded with calcium indicator Fura-2 AM (Mo-
lecular Probes) at 37   °   C for 30 min. Cells were washed twice with 
HBSS, and Ca 2+ mobilization was measured in response to condi-
tioned media (CM) from MCPIP-1-silenced cells infected or not 
infected with  E. coli . After excitation at 340 and 380 nm, the fluo-
rescence-related [Ca 2+ ] changes were monitored at 505 nm, and the 
results were presented as the fluorescence ratio (340 nm/380 nm).
 Cell Transduction 
 Silencing of the  ZC3H12A gene in HeLa cells was achieved us-
ing a lentiviral system. Packaging of plasmids psPAX2 (Addgene 
plasmid cat. No. 12,260) and envelope plasmid pMD2.G (Addgene 
plasmid cat. No. 12,259; kindly provided by Didier Trono) into 
lentiviruses was carried out using a second-generation packaging 
system. For silencing, a plasmid expressing an shRNA sequence 
targeting the  ZC3H12A gene (Sigma, cat. No. TRCN0000130710) 
or a nonspecific scrambled control sequence (Sigma, cat. No. 
SHC002) was used. Overexpression of  ZC3H12A in HeLa cells was 
achieved using a pMX retrovirus system with expression plasmids 
encoding wild-type (WT) human MCPIP-1 (pMX-MCPIP-1) or 
empty pMX-puro. Transduction was carried out in suspension, in 
growth medium mixed 1: 2 with infection medium and 6 μg/ml of 
Polybrene. After 24 h, medium was exchanged for normal growth 
medium; after 3 days puromycin (6 μg/ml) was added to the me-
dium to select transduced cells. Overexpression was verified by 
Western blot analysis after 7 days.
 Cell Transfection 
 Silencing of  MCPIP-1 was achieved by transfection of HeLa 
and Caco-2 cells with the specific siRNAs listed in  table  1 or 
STEALTH siRNA negative control (NC) duplexes (Invitrogen). 
Transfections were performed with cells at 40% confluence. Brief-
ly, 50 pmol of siRNA was combined with 2 μl of Lipofectamine 
2000 (Invitrogen) in Opti-MEM medium, and cells were trans-
fected for 6 h, followed by 48 h of normal cell growth in DMEM 
medium alone prior to assays. The efficiency of silencing was ver-
ified by Western blot analysis.
 Cytokine Assays 
 The levels of IL-8 and IL-6 in HeLa and Caco-2 supernatants 
were determined using commercially available ELISA kits (BD 
Bioscience). Estimation of MCP-1 concentration was performed 
using the BD TM Cytometric Bead Array Human Chemokine Kit 
(BD Biosciences).
 Quantitative Reverse-Transcription PCR 
 Total cellular RNA was extracted from HeLa cells using TRIzol 
(Ambion). Reverse transcription was performed using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). 
Five hundred nanograms of RNA from each sample were used for 
cDNA synthesis with random primers in a total volume of 20 μl. 
Quantitative PCR (qPCR) was performed by the SYBR Green 
method in a reaction volume of 15 μl containing 1 μl of cDNA 
sample, 10 μ M of each primer, and 1× SYBR Green JumpStart Taq 
ReadyMix. qPCRs were performed using forward and reverse 
primers for  MCPIP-1 (ZC3H12A) , IL-8 , IL-6 ,  iNOS , and  EF2 
 (housekeeping gene, used for normalization).  After 5 min of initial 
denaturation at 95  °  C, reactions were carried out for 40 cycles, fol-
lowed by a final elongation step at 72   °   C for 10 min. Primer se-
quences and conditions for denaturation, annealing, and exten-
sion for each pair of primers are provided in  table 2 . All reactions 
were performed in duplicate. Mean threshold cycle (C t ) values 
were calculated and analyzed using the ΔΔC t method  [26] . To eval-
uate the quality of qPCRs, samples were routinely resolved on non-
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 Protein Isolation and Immunoblotting 
 Whole cellular extracts from control, modified, and stimulated 
cells were prepared using 100 μl of RIPA-lysis buffer (0.25% Na-
deoxycholate, 0.5% Nonidet P-40, 0.05% SDS, protease inhibitor 
cocktail, 2.5 m M EDTA in PBS). The protein concentration was 
determined using the BCA protein assay (ThermoFisher Scientif-
ic). Equal amounts of protein (20 μg/well) were separated on 12% 
SDS-PAGE gels and electrotransferred onto PVDF membranes 
(Millipore) in buffer consisting of 25 m M Tris, 0.2  M glycine, and 
20% methanol (100 V, 90 min). Nonspecific binding sites were 
blocked with 5% skimmed milk in TBST buffer (20 m M Tris, pH 
7.5, 0.5  M NaCl, 0.05% Tween 20) for 2 h, followed by overnight 
incubation with the relevant primary antibody: rabbit anti-
MCPIP-1 (1: 2,000, GeneTex) or mouse anti-β-actin (1: 10,000, BD 
Bioscience). Membranes were washed extensively in TBST buffer, 
and then incubated for 2 h in TBST buffer containing 5% skimmed 
milk and horseradish peroxidase-conjugated secondary antibod-
ies: goat anti-rabbit IgG (1: 3,000, Cell Signaling) and goat anti-
mouse (1: 10,000, BD Bioscience). All incubations were performed 
at 4  °  C. Membranes were washed (5 × 5 min) in TBST buffer, and 
blots were developed using Luminata Crescendo Substrate (Mil-
lipore). Membranes were exposed to Kodak medical X-ray film 
and developed. 
 Densitometric Analysis 
 Densitometric analyses of Western blots were performed using 
Kodak digital software. The results are presented as mean values 
in arbitrary densitometric units, corrected for background inten-
sity, or as increases over the corresponding levels in nonstimulated 
cells.
 Protein Expression and Purification 
 The WT human MCPIP-1 nucleotide sequence (NM_025079.2) 
was optimized for efficient expression in  E. coli strains and synthe-
tized by GeneScript (Piscataway, N.J., USA). A synthetic MCPIP-1 
gene was cloned into vector pET-21a (Novagen). Mutant MCPIP-1 
(D141N) was generated by site-directed mutagenesis. WT 
MCPIP-1 and MCPIP-1 (D141N) proteins were overexpressed in 
BL21 RIL  E. coli strain (Novagen) in LB broth at 37  °  C, and protein 
overexpression was induced by the addition of 0.5 m M of IPTG 
when the culture reached an OD 600 of 0.5. MCPIP-1 was purified 
from inclusion bodies by several washing steps combined with 
sonication. Final inclusion body solubilization was performed at 
room temperature in buffer containing 25 m M Tris, 7  M urea, 1 m M 
DTT, pH 9. To obtain a pure fraction of MCPIP-1 protein, TMAE 
resin (Merck) ion-exchange chromatography was performed un-
der denaturing conditions. For elution, the buffer was enriched to 
1  M NaCl. The first step of the refolding procedure was performed 
by dilution of MCPIP-1 to 1 mg/ml in buffer containing 25 m M 
Tris, 500 m M NaCl, 1.8  M urea, 5 m M DTT, and 1 m M EDTA, pH 
8.3 at 4  °  C. The diluted sample was incubated at 4  °  C for 6 h. Sub-
sequently, overnight dialysis at 4  °  C was performed against native 
buffer: 25 m M Tris, 300 m M NaCl, 1 m M DTT, 1 m M EDTA, pH 
8.3. Refolded fractions were concentrated to 10 mg/ml by ultracen-
trifugation using Amicon Ultra 30K centrifugal filters (Merck), 
and then purified by size-exclusion chromatography using Super-
dex 200 prep grade HR 30/10 column (GE Healthcare). All recom-
binant MCPIP-1 activity assays were performed on protein that 
had never been frozen.
 RNA Synthesis  
 The cDNA sequence of IL-8 (CDS + 3 ′ UTR) [NM_000584.3 
from 133 to 1705 nt.] was amplified from HeLa cDNA with prim-
ers 5 ′ -ACCATCTCACTGTGTGTAAACA-3 ′ and 5 ′ -TTACTTT-
GACAACAAATTATATTTTAAATGT-3 ′ . The PCR product was 
phosphorylated and cloned into pcDNA3.0 vector (Invitrogen) at 
blunted  Hin dIII and  Eco RI sites. Prior to mRNA synthesis, the 
template was linearized at the  Eco RV site. mRNA was synthesized 
in vitro using the TranscriptAid T7 High Yield Transcription Kit 
(ThermoFisher), followed by purification by phenol-chloroform 
extraction and ethanol precipitation  [27] .
 In vitro RNA Cleavage Assay 
 Endonuclease activity tests of WT MCPIP-1 were performed 
on IL-8 transcript (CDS + 3 ′ UTR). Samples were mixed at a molar 
ratio of 1: 5 (1 pmol of RNA to 5 pmol of WT MCPIP-1) and in-
Oligonucleotide Sequence Temperature 
program1
EF2_R 5′-TTCAGCACACTGGCATAGAGGC-3′ 1. 95° C, 30 s
2. 62° C, 30 s




IL-6_R 5′-AGTGCCTCTTTGCTGCTTTCACAC-3′ 1. 95° C, 30 s
2. 58° C, 30 s




IL-8_R 5′-TCTCAGCCCTCTTCAAAAACTTCT-3′ 1. 95° C, 30 s
2. 60° C, 1 min




1 Denaturation (1); annealing (2); extension (3).
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cubated at 37   °   C in reaction buffer (50 m M Tris, 150 m M NaCl,
2.5 m M MgCl 2 , 2.5 m M DTT, 0.5 m M EDTA, 0.025 m M ZnCl 2 ,
pH 8.3). Final sample volumes were 20 μl. Samples in each time 
point were frozen to stop the reaction. After cleavage, samples were 
denatured for 15 min at 70   °   C and analyzed by 4% denaturing 
PAGE in TBE buffer. Gel was stained in 100 ml of TBE buffer with 
the addition of 10 μl of SimpleSafe TM dye (EuRX) and visualized 
using a ChemiDoc system (Bio-Rad). 
 EMSA Assay 
 MCPIP-1 (D141N) was incubated with synthesized IL-8 (CDS 
+ 3 ′ UTR) mRNA in reaction buffer containing 25 m M Tris, 150 
m M NaCl, 2.5 m M MgCl 2 , 2.5 m M DTT, 0.5 m M EDTA, 0.025 m M 
ZnCl 2 , 5% w/v glycerol, pH 8.3. Samples were mixed with 2 pmol 
of RNA (RNA:protein molar ratio as 1: 0, 1: 25, or 1: 50) and incu-
bated for 20 min on ice. Subsequently, complexes were separated 
by electrophoresis through 0.8% agarose gel that was prepared us-
ing 1× TAE buffer and SimpleSafe TM dye.
 Computational Analysis 
 Calculations of ΔG of RNA stem-loop structures were per-
formed using mFOLD software  [28] . 
 RNA-Protein Immunoprecipitation 
 HeLa cells were infected with  E. coli for 8 h. Subsequently, cells 
were crosslinked with 1% formaldehyde for 10 min, and then 
washed with PBS containing 1 m M PMSF and 125 m M glycine. 
Cells were scraped from the plate with a rubber policeman, cen-
trifuged at 280  g for 8 min at 4   °   C, and then incubated on ice for
30 min in lysis buffer (100 m M KCl, 25 m M EDTA, 2 m M DTT,
10 m M HEPES, 0.5% NP-40, 1× complete protease inhibitor cock-
tail). Lysates were centrifuged at 14,000  g for 5 min at 4  °  C, and the 
resultant supernatants were diluted with IP buffer (50 m M NaCl,
1 m M EDTA, 2 m M DTT, 50 m M HEPES, pH 7.5, 10% glycerol, 
0.5% Triton X-100, complete protease inhibitor cocktail). Protein 
A agarose (Roche) was prepared for precleaning of the lysate by 
washing with IP buffer and blocking with 1% BSA, followed by the 
addition of anti-MCPIP-1 antibodies. Beads were incubated over-
night at 4  °  C with constant mixing, and lysates were added the next 
day. After incubation for an additional 10 h, the immunoprecipi-
tates were centrifuged at 400  g for 1 min at room temperature and 
washed five times with IP buffer. RNA-protein complexes were 
eluted from beads with RIP buffer (100 m M NaCl, 5 m M EDTA,
10 m M DTT, 50 m M HEPES, pH 7.5, 10% glycerol, 0.5% Triton 
X-100, 1% SDS, 1× complete protease inhibitor cocktail) with 
RNase inhibitor (Invitrogen). After elution, crosslinks were re-
versed by incubation at 70  °  C for 1 h, and the samples were centri-
fuged at 400  g for 1 min at room temperature. From the resultant 
supernatant, RNA was isolated using the TRIzol reagent, reverse 
transcribed, and subjected to qPCR analysis.
 Statistical Analysis 
 All experiments were performed at least in triplicate, and re-
sults were analyzed for statistical significance using parametric and 
nonparametric Student’s t tests. All values are expressed as means 
± SD, and differences were considered significant at p < 0.05.
 Results 
 High Constitutive Expression of MCPIP-1 in Epithelial 
Cells 
 In contrast to the known function of MCPIP-1 in my-
eloid cells, its physiological role in the epithelium is poor-
ly understood  [14, 21, 29] . Moreover, unlike its transcript 
distribution, the levels of MCPIP-1 protein in different 
human tissues have not yet been assessed  [13] . Thus, we 
evaluated the distribution of MCPIP-1 protein in several 
epithelial and myeloid cell lines as well as primary cell 
cultures. Surprisingly, this analysis revealed that the 
MCPIP-1 protein was constitutively produced in epithe-
lial cells. Robust MCPIP-1 protein expression was higher 
in skin and gingival keratinocytes, hepatocytes, and cer-
vix, kidney, stomach, and colon epithelium than in my-
eloid cells such as PBMCs, monocytes, macrophages, and 
moDCs ( fig.  1 a, b, d). This observation suggested that 
MCPIP-1 is functionally important in the epithelium. 
Moreover, we observed weak correlations between tran-
script and protein levels, suggesting that MCPIP-1 is
regulated by diverse mechanisms in different cell types 
( fig .  1 c, d). Because MCPIP-1 mRNA and protein were 
 Fig. 1. Comparison of mRNA and protein MCPIP-1 expression in 
various epithelial and myeloid cells. Total  RNA and protein was 
isolated from 1 million cells of each type.  a Representative West-
ern blots of protein lysates isolated from PBMCs, Mo, hMdMs, 
moDCs, KB, TIGKs, and primary skin keratinocytes (KC) (upper 
panel). Coomassie staining shows equal protein loading in each 
well (lower panel).  b Comparison of MCPIP-1 protein expression 
between different myeloid [U937 (×), THP-1(#), hMDMs ( * ) ob-
tained from 5 different donors, monocytes (§), MoDCs ( ☉ )] and 
epithelial cells [primary skin keratinocytes obtained from 3 differ-
ent donors ( ◆ ), TIGKs (⚪), HEK 293T ( ◇ ), HeLa (◼), KB (◻), 
Caco-2 ( ▼ ), KATO III ( ▲ ), Hep-G2 (⚫)]. The graph represents 
the MCPIP-1 protein level, estimated by densitometric analysis of 
Western blots.  c MCPIP-1 mRNA and protein levels in seven dif-
ferent cell lines. Transcript levels were determined by qRT-PCR. 
The graph represents the cycle number at which the fluorescence 
signal crossed the threshold (C t ) for EF2 (reference gene) and 
 MCPIP-1 . For differences in cycle number between the gene of in-
terest and the reference gene (ΔC t ) and the changes in gene expres-
sion across samples (2 ΔΔCt ), representative results from three inde-
pendent experiments are presented.  d Representative results of 
Western blotting with specific anti-MCPIP-1 antibodies (upper 
panel). Coomassie staining confirms equal protein loading in each 
well (lower panel). Bars represent mean relative expression levels 
± SD;  *  p < 0.05, indicating a significant difference;  **  p < 0.01. 
(For figure see next page.)
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both abundantly expressed in HeLa cells, we chose this 
cell line as a model for studying the role of this regulator 
in the epithelium.
 The Role of MCPIP-1 in the Regulation of IL-8 
Expression in Epithelial Cells 
 Epithelia represent dynamic barriers between the ex-
ternal environment and the organism’s interior. Accord-
ingly, their integrity is of central importance, and they 
play crucial roles in response to injury. Moreover, epithe-
lia are a source of vitamin D and keratins, which are in-
volved in intracellular signaling pathways with regulatory 
functions such as stress-response and wound healing  [30, 
31] . In innate immunity, one critical role of epithelia is 
the detection of pathogens and mobilization of neutro-
phil recruitment to the site of infection  [5] . Therefore, we 
decided to investigate the potential role of MCPIP-1 in 
the regulation of IL-8 expression, the main chemokine 
involved in neutrophil attraction to an infection site  [4] . 
Briefly, siRNA and shRNA were used to silence the 
 MCPIP-1 gene. Treatment of cells with MCPIP-1-spe-
cific siRNA and shRNA, but not a nonspecific control 
siRNA/shRNA (NC), resulted in the upregulation of IL-8 
secretion up to 2.4-fold (for the si4 sequence) relative to 
that in control cells ( fig. 2 a). In further experiments, we 
found that an shRNA1 that lowered the constitutive 
MCPIP-1 protein expression by 77% (4.35 ± 0.12-fold de-
crease;  fig. 2 b) resulted in higher IL-8 secretion than in 
cells treated with the control shRNA ( fig. 2 b). Simultane-
ously, we tested the effect of the same shRNA (shRNA1) 
on the expression levels of IL-6  [21] , which is modulated 
by the RNase activity of MCPIP-1, and MCP-1  [32] 
( fig. 2 b), which is not. The results revealed that a reduc-
tion in the intracellular MCPIP-1 level caused a signifi-
cant increase in IL-8 and IL-6 expression, but not in 


































RNA IL-8 secretion (pg/ml)
si NC 30.43 ± 3.19
si1 41.68 ± 4.29
si2 45.40 ± 5.66*
si3 41.99 ± 4.30
si4 85.64 ± 17.01**
si5 46.16 ± 5.96*
si6 43.78 ± 5.06*
sh NC 39.53 ± 5.56
sh1 64.10 ± 3.94**
a
 Fig. 2. Influence of MCPIP-1 on the consti-
tutive expression of IL-8 in HeLa cells.
 a  MCPIP-1 was silenced in HeLa cells us-
ing specific siRNA or shRNA sequences; 
scrambled nonselective sequences were 
used as NCs. The level of secreted IL-8 was 
determined by ELISA.  b Levels of the se-
creted cytokines IL-8 and IL-6 in shRNA1 
MCPIP-1-silenced HeLa cells were esti-
mated by ELISA, and the MCP-1 level was 
detected using a cytometric bead array. 
Data represent mean secreted cytokine 
concentrations from three independent ex-
periments ± SD.  *   p < 0.05;  * *   p < 0.01.
n.s. = Not significant. The efficiency of
silencing was verified by Western blot 
(above).  

























 IL-8 secretion post-E. coli infection (pg/ml)
RNA 3  h 8 h 24 h
si NC 25.23 ± 6.75 1,042.51 ± 212.20 1,146.03 ± 229.10
si1 41.24 ± 9.64 2,151.89 ± 594.20 2,119.41 ± 308.40*
si2 46.38 ± 15.80 1,346.73 ± 113.4 1,469.46 ± 159.70
si3 74.58 ± 25.45* 1,706.36 ± 58.03* 2,484.64 ± 274.40*
si4 81.77 ± 17.49** 2,167.79 ± 259.50** 2,026.40 ± 32.75
si5 57.50 ± 24.17 1,306.22 ± 156.00 1,517.73 ± 63.26
si6 47.88 ± 8.25 1,135.43 ± 226.80 1,138.47 ± 202.00
sh NC 3.49 ± 0.60 76.55 ± 6.15 91.88 ± 13.48








































 Fig. 3. Influence of MCPIP-1 on  E. coli -in-
duced expression of IL-8 in HeLa and 
Caco-2 cell lines.  a ,  b M CPIP-1 was si-
lenced in HeLa cells using specific siRNA 
or shRNA sequences; scrambled nonselec-
tive sequences were used as NCs. The cells 
were subsequently infected with  E. coli . Af-
ter the indicated times, culture media were 
collected and the level of IL-8 was estimat-
ed by ELISA.  c  MCPIP-1 was silenced in 
Caco-2 cells using three specific siRNAs; 
scrambled nonselective sequences were 
used as NCs. The level of MCPIP-1 protein 
after transfection was determined by West-
ern blotting (above). The IL-8 level was es-
timated in culture media of noninfected 
and  E. coli- infected cells (24 h postinfec-
tion). Levels of secreted IL-8 from three in-
dependent experiments are presented as 
absolute values (pg/ml) ± SD.  *  p < 0.05; 
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observed in primary keratinocytes, in which downregula-
tion of MCPIP-1 led to elevated secretion of IL-8 (data 
not shown). Thus, MCPIP-1 negatively regulates IL-8 ex-
pression in epithelial cells. 
 The Role of MCPIP-1 in the Postinfectious Regulation 
of IL-8 in the Epithelium 
 IL-8 expression is upregulated under multiple patholog-
ical conditions, including infections  [33] . We confirmed 
increased IL-8 synthesis in epithelial cells upon infection 
with Gram-negative bacteria ( fig. 3 a) and examined the im-
pact of MCPIP-1 on the expression of proinflammato-
ry mediators during the time course of infection. Brief-
ly, using the same silencing sequence (sh1), we evaluated 
MCPIP-1-dependent regulation of IL-8 secretion after
 E. coli infection. The results revealed that silencing of 
 MCPIP-1 expression significantly increased the IL-8 con-
centration in CM as early as 8 h postinfection and that the 
effect lasted up to 24 h ( fig. 3 a). Using other silencing se-
quences, we not only confirmed the suppression of IL-8 
expression by MCPIP-1, but also showed that this effect 
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 Fig. 4. Biological consequences of MCPIP-1 downregulation.
 a Mobilization of intracellular free calcium levels in Fura-2-loaded 
cells was monitored by spectrofluorometry after the treatment of 
neutrophils with culture media collected from noninfected and
 E. coli -infected HeLa cells (shNC – NC, shRNA MCPIP-1 si-
lenced); the arrow indicates the time of media addition. Represen-
tative ratios of fluorescence intensities (340/380 nm) from three 
independent experiments are shown.  b M CPIP-1 was silenced in 
HeLa cells using specific siRNA or shRNA sequences; scrambled 
nonselective sequences were used as NCs. Forty-eight hours later, 
cells were infected with  E. coli  for  8 and 24 h. The level of  iNOS 
 mRNA, determined by RT-PCR, was calculated across the sam-
ples; the value in the NC sample was defined as 1.  c Four hours 
after  E. coli infection of MCPIP-1-silenced HeLa cells (MOI = 5), 
cell lysates were collected and plated onto LB agar for the counting 
of intracellular bacteria (CFU). Data represent mean values from 
three independent experiments ± SD.  *  p < 0.05;  **  p < 0.01.  
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 We investigated the biological effects of IL-8 regula-
tion by MCPIP-1 in primary granulocytes (PMNs), which 
represent a population of cells that are highly responsive 
to this chemokine. In PMNs treated with CM from 
MCPIP-1-silenced HeLa cells, elevated production of 
IL-8 increased mobilization of calcium ions ( fig. 4 a). This 
effect was augmented when cells were exposed to CM col-
lected from  E. coli -infected cells ( fig. 4 a). Additionally, to 
confirm the paracrine influence of IL-8 secretion on tran-
scriptional activation in HeLa cells, we measured expres-
sion of  iNOS , which encodes a potent proinflammatory 
factor and is strongly upregulated by IL-8  [34] . The re-
sults revealed that  iNOS expression was elevated in re-
sponse to higher IL-8 secretion in MCPIP-1-silenced 
HeLa cells in comparison to NC cells, irrespective of 
whether they were infected with  E. coli ( fig. 4 b). Finally, 
to investigate the role of MCPIP-1 in the progress of  E. 
coli infection in epithelial cells, we monitored the rate of 
bacterial eradication. MCPIP-1-silenced cells cleared in-
fection significantly more efficiently than control cells 
( fig. 4 c). Taken together, these data indicate that MCPIP-1 
plays an important role in the regulation of inflammation 
during bacterial infection of HeLa cells. To verify if the 
























































 Fig. 5. Effect of  MCPIP-1 overexpression in 
HeLa cells on constitutive and  E. coli -in-
duced IL-8 levels.  a Levels of MCPIP-1 in 
HeLa cells after transduction with empty 
vector or expression plasmid-harboring 
WT  MCPIP-1 was verified by Western 
blotting (above). Using conditioned media, 
IL-8 and IL-6 protein levels were deter-
mined by ELISA, and the MCP-1 level by 
cytometric bead array. Bars represent the 
mean concentrations of secreted cytokines 
± SD.  b Control and  MCPIP-1 -overex-
pressing cells were infected with  E. coli . At 
the indicated times postinfection, media 
were harvested and levels of secreted IL-8 
were estimated by ELISA. Data represent 
mean values from three or four indepen-
dent experiments ± SD.  *  p < 0.05;  * *  p < 
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used Caco-2 cells silenced with three of the tested siRNA 
sequences. Because silencing in Caco-2 cells was not as 
efficient as in HeLa cells ( fig. 3 c), the high endogenous 
expression of IL-8 flattened the final readout. Nonethe-
less, the results once again confirmed that both constitu-
tive and infection-induced levels of IL-8 were higher in 
 MCPIP-1 -deficient cells ( fig. 3 c), indicating that the sup-
pression of IL-8 expression by  MCPIP-1 is a common
feature of epithelial cells. Additionally, we investigated 
whether high constitutive MCPIP-1 expression in epithe-
lial cells contributes to the preservation of immune ho-
meostasis by assessing the effect of MCPIP-1 overexpres-
sion (from a transfected plasmid) in HeLa cells. Overex-
pression of MCPIP-1 led to a 5.6-fold increase in its 
protein level ( fig. 5 a), which correlated significantly with 
lower secretion of IL-8 by both noninfected and infected 
cells ( fig. 5 a, b). A similar effect was noted for the IL-6 
transcript specifically targeted by MCPIP-1, whereas the 
level of the control transcript (MCP-1) was unaffected 
( fig. 5 a). Taken together, the results show that MCPIP-1 
regulates both the physiological and postinfectious ex-
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 Fig. 6. MCPIP-1 directly regulates the stability of IL-8 mRNA.  a Purity of recombinant MCPIP-1 protein (WT 
and D141N) used in the experiments, documented by SDS PAGE.  b Degradation of IL-8 transcript by recombi-
nant MCPIP-1 protein (WT), estimated by in vitro RNA cleavage assay.  c Interaction of recombinant MCPIP-1 
lacking RNase activity (D141N) with the IL-8 transcript (CDS + 3 ′ UTR), estimated by EMSA. Results are repre-
sentative of three independent experiments.  
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 The Mechanism of IL-8 Regulation by MCPIP-1  
 It was previously shown that the regulation of the
expression of several proinflammatory cytokines by 
MCPIP-1 depends on its deubiquitinase or RNase ac-
tivity  [13, 22] . Therefore, to determine the mechanism
of action and its impact on IL-8 transcript degrada-
tion, we expressed and purified recombinant MCPIP-1 
(rMCPIP-1) with and without the D141N mutation, 
which inactivates its nuclease activity  [13, 19, 21] ( fig. 6 a). 
First, we performed the RNA cleavage assay. Incubation 
of IL-8 (CDS + 3 ′ UTR) mRNA with WT rMCPIP, but not 
with the D141N mutant, resulted in time-dependent deg-
radation of IL-8 mRNA, confirming its endonuclease ac-
tivity ( fig. 6 b). The full-length IL-8 transcript (1,621 nt) 
was degraded in 1 h to a  ∼ 600-nt transiently stable prod-
uct, which then underwent further gradual cleavage into 
several  ∼ 100 nt products after 20 h incubation. This deg-
radation pattern indicates that some elements in the IL-8 
(CDS + 3 ′ UTR) transcript were preferentially recognized 
and processed by MCPIP-1. Thereafter, we examined rec-
ognition of IL-8 mRNA by MCPIP-1 using the D141N 
mutated rMCPIP-1 protein, which is devoid of nuclease 
activity. The IL-8 transcript showed retarded mobility, 
indicating complex formation between MCPIP-1 and 
IL-8 (CDS + 3 ′ UTR) mRNA ( fig. 6 c). 
 The above findings motivated us to search for stem-
loop elements that might be important for the regulation 
of IL-8 mRNA stability and its recognition and cleav-
age by MCPIP-1. Briefly, the alignment of stem-loop
sequences of IL-8 mRNA in different species revealed
a high structural similarity among transcripts (online
suppl. fig. S1; for all online suppl. material, see www.
karger.com/doi/10.1159/000448038). Additionally, pre-
liminary analysis of the 3 ′ UTR region of the IL-8 mRNA 
sequence revealed that is has the potential to form con-
served stem-loop structures (online suppl. fig. S1). 
Moreover, the low ΔG values (ΔG 1 in the range from 
–11.2 to –11.3) of these particular IL-8 structures indicate 
their stability and suggest that they are important for IL-8 
recognition by MCPIP-1 RNase (online suppl. fig. S1). 
These results are consistent with the fact that other stem-
loop motifs are recognized by MCPIP-1, such as the con-
served loop-structures in the IL-6 transcript  [22] . Never-
theless, we confirmed the importance of the stem-loop 
motifs by performing an immunoprecipitation assay.
 Lysates from noninfected HeLa cells and cells obtained 
8 h after infection with  E. coli were incubated with spe-
cific MCPIP-1 antibodies. The pull-down fraction was 
enriched in cytokine mRNAs that are substrates for 
MCPIP-1 RNase ( fig. 7 , right panel). The left panel shows 
increased expression of the indicated cytokines in unpro-
cessed whole-cell lysates infected and noninfected with
 E. coli . The right panel shows the level of transcripts in the 
pull-down fraction obtained by immunoprecipitation 
with the MCPIP-1 antibody, in which the IL-6 and MCP-
1 transcript served as positive and negative controls, re-
spectively. These results showed that, despite the increase 
in the levels of different cytokine mRNAs in the lysates of 
infected cells, only IL-8 and IL-6 were detected in the im-
munoprecipitates, confirming that IL-8 mRNA was ex-
plicitly recognized by the MCPIP-1 protein. Collectively, 
the results indicate that MCPIP-1 regulates epithelial ho-
meostasis in a specific manner via recognition and degra-
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 Fig. 7. Specificity of transcript recognition 
by MCPIP-1. Expression levels of proin-
flammatory cytokines (IL-6, IL-8, and 
MCP-1) in  E. coli- infected HeLa cells and 
mock-infected cells (C) were compared by 
qPCR. The left panel (lysates) shows tran-
script levels in unprocessed whole-cell ly-
sates. The right panel (RNA-IP) shows 
transcript levels in the pull-down fraction 
obtained by immunoprecipitation of cell 
lysates with anti-MCPIP-1 antibodies. For 
each cytokine, the transcript level in mock-
infected cells was defined as 1. Therefore, 
in both panels, the C bar represents the 
transcript level for each cytokine in mock-
infected cells. Results are representative of 








 Pattern recognition receptors are critical players in in-
nate and adaptive immune systems for sensing invading 
microorganisms and activating multiple pathways that 
lead to the induction of proinflammatory responses essen-
tial for pathogen clearance. The intensity and duration of 
defense against invading pathogens must be tightly con-
trolled in every tissue at various time points. These features 
are maintained by an array of positive and negative regula-
tors. We hypothesized that MCPIP-1, an important nega-
tive regulator of proinflammatory responses in myeloid 
cells, might also play an important role in maintaining ho-
meostasis in the epithelium, both under physiological con-
ditions as well as upon bacterial infection. 
 Previous reports on the tissue distribution of MCPIP-1 
focused mainly on its transcript level  [13] . However, the 
transcript level of a gene does not always provide informa-
tion about the true level of protein due to posttranscrip-
tional RNA processing. Therefore, we determined the 
protein level of MCPIP-1 in different cell types. The re-
sults showed ubiquitous expression of MCPIP-1 in vari-
ous epithelial cells and surprisingly higher levels MCPIP-1 
protein in epithelial cells than in myeloid cells, which con-
tradicts the results of previous analyses based on tran-
scriptome analysis. The divergent expression levels could 
be related to differences in the proliferation rate or cell 
culture conditions; nonetheless, significant correlations 
were observed (online suppl. table S1). It is also reasonable 
to postulate the presence of distinct, cell-specific regula-
tory mechanisms that affect MCPIP-1 expression and 
transcript processing. The elevated level of MCPIP-1 pro-
tein in epithelial cells may indicate that the  MCPIP-1 tran-
script is more stable in epithelial cells. Alternatively, re-
duced ubiquitin modification or proteolytic truncation 
exerted by MALT-1 may be responsible for the higher 
MCPIP-1 protein level. Indeed, a number of studies pro-
vide evidence that MALT-1 is expressed and functions in 
NF-κB activation in nonimmune cells, including epithe-
lial cells  [35] . However, the extent to which MALT-1 af-
fects MCPIP-1 function or helps determine its mechanism 
of action in immune and nonimmune cells remains un-
clear and represents a challenge for future investigations 
 [36] . In summary, our observations suggest that MCPIP-1 
has an important role not only in the myeloid lineage, but 
also in epithelial cells. In tissues that are continually ex-
posed to microorganisms, such as skin, oral cavity, or co-
lon, increased expression of negative regulators of the in-
nate immune responses, such as MCPIP-1, may constitute 
an important mechanism for dampening immune re-
sponses. This could open up new opportunities for the 
development of novel treatments for inflammatory dis-
eases involving mucosal as well as epidermal linings. 
 One of the major inflammatory mediators secreted by 
epithelial cells in response to invaders is chemokine IL-8. 
Abnormalities in epithelial IL-8 secretion are associated 
with various inflammatory diseases, such as inflammatory 
bowel disease, asthma, and psoriasis, indicating that its 
strict control is pivotal for the maintenance of epithelial 
hyporesponsiveness  [37–39] . Our results clearly showed 
that MCPIP-1 plays an important role in this process by 
exerting RNase activity towards the IL-8 transcript. We 
found that the lifespan of IL-8 is determined by the pres-
ence of stem-loops/hairpin structures in the 3 ′ UTR region 
of IL-8 mRNA, which are conserved between species as 
shown by the results of computational analysis. These 
conserved structures are targeted by the MCPIP-1 PIN 
domain and share many similarities with those that regu-
late the stability of the IL-6 transcript  [22] . Our results 
showed that the recombinant MCPIP-1 mutant protein 
lacking RNase activity recognizes IL-8 mRNA but does 
not affect its integrity. However, using fully active, puri-
fied rMCPIP-1, we demonstrated rapid degradation of the 
IL-8 transcript only 1 h after the coincubation of the IL-8 
transcript with rMCPIP-1 RNase. Our results comple-
ment and expand the results published by Mino et al.  [40] , 
who showed that IL-8 mRNA associated with MCPIP-1 
exclusively in noninfected HeLa cells. In line with these 
findings, we observed higher levels of IL-8, both at the 
mRNA level and protein level, in MCPIP-1 knockdown 
cells than in native cells. Although this effect was specific 
for IL-8, and the expression of other chemokines, such as 
CXCL-10 and CCL-5, was not significantly affected by 
MCPIP-1 (data not shown), it would be useful to investi-
gate the MCPIP-1-dependent posttranscriptional regula-
tion of other relevant chemokines. Taken together, these 
results suggest that a high level of MCPIP-1 in the epithe-
lium can downregulate the constitutive expression of IL-8. 
The loss of MCPIP-1-mediated control following deple-
tion leads to a wide range of physiological effects, includ-
ing granulocyte activation (calcium mobilization) and
upregulation of inflammatory mediators such as iNOS, 
which is induced in an autocrine fashion by IL-8 in the 
epithelium. Finally, using the  E. coli infection model in 
HeLa cells, we investigated the role of MCPIP-1 in epithe-
lial cells upon exposure to pathogens. The results suggest 
that MCPIP-1 expression in epithelial tissue decreases the 
level of IL-8 transcript, as well as translated IL-8, in the 
early stage of infection, as in noninfected cells. At this 
stage of infection, the level of IL-8 expression is regulated 
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not only by de novo synthesis mediated by NF-κB activa-
tion  [33] , but also posttranscriptionally by MCPIP-1. 
However, because the modulation of MCPIP-1 by patho-
gens cannot be excluded, our proposed mechanism for 
IL-8 regulation may be oversimplified. Recent work 
showed that the MCPIP-1 mRNA is controlled by the ac-
tivation of TLRs; however, the posttranslational modifica-
tion of this protein in response to infection has not been 
analyzed. The importance of high MCPIP-1 expression in 
the epithelium was confirmed by overexpression of 
MCPIP-1, which resulted in significant but nonetheless 
minor downregulation of IL-8 secretion. The role of high-
ly abundant MCPIP-1 was also highlighted by the more 
efficient eradication of  E. coli , concomitant with elevated 
expression of  iNOS ,  in MCPIP-1-silenced cells. Although 
the involvement of ROS/RNS in the response to infection 
in epithelial cells remains poorly documented, some stud-
ies suggest that this pathway plays an important role in 
eliminating bacterial infection  [41] . Accordingly, it is rea-
sonable to speculate that bacterial invasion initiates the 
process of MCPIP-1 depletion, leading to increased sus-
ceptibility to pathogens. Therefore, it would be worth-
while to investigate the regulation of MCPIP-1 expression 
and its posttranslational modification during infection. 
 Pattern recognition receptor pathway activation in the 
epithelium is controlled by low expression of PAMP re-
ceptors but also by increases in the levels of its negative 
regulators  [8, 10, 42] . Some of these regulators are ex-
pressed constitutively, whereas others are upregulated 
during inflammation. The latter category is represented 
by A20, the concentration of which increases rapidly in 
epithelial cells following stimulation with TNF-α or TLR 
ligands  [7] . In this respect, MCPIP-1 cannot be classified 
as an ‘acute-phase’ negative regulator in epithelial cells, as 
we did not observe its upregulation during infection (data 
not shown). Interestingly, SIGIRR, another negative IL-
1R/TLR signaling regulator, shows a similar expression 
pattern to that of MCPIP-1 and is highly expressed in 
many epithelial cell lines but not in primary macrophages, 
fibroblasts, or endothelial cells  [8] . 
 In conclusion, we uncovered a novel IL-8-dependent 
mechanism by which MCPIP-1 maintains immune ho-
meostasis, which is of significance for epithelial linings. 
This study reveals for the first time that MCPIP-1 plays an 
anti-inflammatory role not only in myeloid cells, but also 
in epithelial cells. On the one hand, inhibition of the host’s 
immune response and restriction of IL-8-dependent neu-
trophil infiltration may help to quickly restore the immu-
nological balance but, on the other hand, may contribute 
to the onset of infection. Additional investigations are 
necessary to elucidate its precise role in orchestrating the 
host’s defense mechanisms in diverse epithelial tissues. 
Elucidation of these mechanisms in detail might contrib-
ute to the development of immunomodulatory therapeu-
tic agents as well as help to identify individuals predis-
posed to prolonged activation of inflammatory responses. 
Finally, we showed that MCPIP-1 maintains cytokine bal-
ance in normal as well as bacteria-stimulated cells, indi-
cating that it contributes to homeostasis in bacteria-ex-
posed epithelial surfaces.
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